Page last updated: 2024-10-22

albuterol and Arrhythmia

albuterol has been researched along with Arrhythmia in 47 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Research Excerpts

ExcerptRelevanceReference
"To determine whether initiation of salmeterol and fluticasone propionate treatment together improves asthma control greater than initiation of monotherapy with the individual agents alone with no additional safety risk in patients with asthma who had not previously been treated with inhaled corticosteroids."9.09Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma. ( Chervinsky, P; Gross, G; Pearlman, DS; Prillaman, B; Shah, T; Stricker, W; Weinstein, S; Woodring, A, 1999)
"Twenty asthmatic patients clinically free of heart disease were studied for the possible arrhythmogenic action of albuterol (salbutamol)."9.06Asthma, cardiac arrhythmias, and albuterol aerosol. ( Lazzari, JO; Martelli, NA; Raimondi, AC, 1986)
"We compared the frequency and severity of cardiac arrhythmias during combined oral theophylline and inhaled salbutamol vs."9.06Theophylline and salbutamol in combination in patients with obstructive pulmonary disease and concurrent heart disease: effect on cardiac arrhythmias. ( Huikuri, H; Korhonen, UR; Linnaluoto, M; Poukkula, A, 1989)
"A retrospective, case-controlled analysis comparing patients admitted to a medical intensive care unit with severe exacerbations of asthma who received continuously nebulized albuterol (CNA) versus intermittent albuterol (INA) treatments is reported."7.69Continuously nebulized albuterol in severe exacerbations of asthma in adults: a case-controlled study. ( Baker, EK; Marinac, JS; Salzman, GA; Willsie, SK, 1997)
"Hemodynamic alterations were studied to determine their role in isoproterenol-induced cardiac arrhythmias in the desoxycorticosterone acetate--saline-treat rat."7.66Hemodynamic alterations in isoproterenol-induced cardiac arrhythmias in corticoid-treated rats. ( Barletta, MA; Guideri, G; Lehr, D, 1978)
"In critically ill adult patients, nebulized albuterol and ipratropium does not cause significant tachycardia or tachyarrhythmias."5.15Effects of nebulized bronchodilator therapy on heart rate and arrhythmias in critically ill adult patients. ( Barber, KR; Khorfan, FM; Smith, P; Watt, S, 2011)
"To determine whether initiation of salmeterol and fluticasone propionate treatment together improves asthma control greater than initiation of monotherapy with the individual agents alone with no additional safety risk in patients with asthma who had not previously been treated with inhaled corticosteroids."5.09Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma. ( Chervinsky, P; Gross, G; Pearlman, DS; Prillaman, B; Shah, T; Stricker, W; Weinstein, S; Woodring, A, 1999)
"Twenty asthmatic patients clinically free of heart disease were studied for the possible arrhythmogenic action of albuterol (salbutamol)."5.06Asthma, cardiac arrhythmias, and albuterol aerosol. ( Lazzari, JO; Martelli, NA; Raimondi, AC, 1986)
"We compared the frequency and severity of cardiac arrhythmias during combined oral theophylline and inhaled salbutamol vs."5.06Theophylline and salbutamol in combination in patients with obstructive pulmonary disease and concurrent heart disease: effect on cardiac arrhythmias. ( Huikuri, H; Korhonen, UR; Linnaluoto, M; Poukkula, A, 1989)
" We assessed characteristics associated with continuous albuterol therapy and, for those treated, duration of therapy and the proportion who clinically deteriorated (ICU transfer or progression to enhanced respiratory support) or who were identified as having hypokalemia or an arrhythmia."3.80Safety and effectiveness of continuous aerosolized albuterol in the non-intensive care setting. ( Fieldston, ES; Kenyon, CC; Keren, R; Luan, X; Zorc, JJ, 2014)
"A retrospective, case-controlled analysis comparing patients admitted to a medical intensive care unit with severe exacerbations of asthma who received continuously nebulized albuterol (CNA) versus intermittent albuterol (INA) treatments is reported."3.69Continuously nebulized albuterol in severe exacerbations of asthma in adults: a case-controlled study. ( Baker, EK; Marinac, JS; Salzman, GA; Willsie, SK, 1997)
"Arrhythmia was induced by the investigated drugs, injected intravenously: adrenaline (ADR); noradrenaline (NA); phenylephrine (PE); isoprenaline (IP); terbutaline (Tb) and salbutamol (Sb)."3.68Sympathomimetic amines and cardiac arrhythmias. ( Akavia, E; Korczyn, AD; Oppenheimer, E; Shavit, S, 1990)
"Hemodynamic alterations were studied to determine their role in isoproterenol-induced cardiac arrhythmias in the desoxycorticosterone acetate--saline-treat rat."3.66Hemodynamic alterations in isoproterenol-induced cardiac arrhythmias in corticoid-treated rats. ( Barletta, MA; Guideri, G; Lehr, D, 1978)
"Hypokalemia and arrhythmias (particularly ventricular arrhythmias) are potential complications."2.82Retrospective evaluation of acute salbutamol (albuterol) exposure in dogs: 501 cases. ( Bates, N; Crouchley, J, 2022)
"In conclusion, in this large cohort of COPD patients with no or stable cardiac comorbidities, a high proportion ( approximately 40%) of patients were observed to have atrial tachycardia before treatment, which increased by 2%-5% with LABA treatment."2.73Arrhythmias in patients with chronic obstructive pulmonary disease (COPD): occurrence frequency and the effect of treatment with the inhaled long-acting beta2-agonists arformoterol and salmeterol. ( Baumgartner, RA; Cheng, H; Grogan, DR; Hanrahan, JP; Morganroth, J; Wilson, A; Zimetbaum, PJ, 2008)
" The frequency of adverse events, COPD exacerbations, and use of short-acting bronchodilator agents were assessed throughout the study period."2.73Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and tolerance. ( Baumgartner, RA; Donohue, JF; Goodwin, E; Grogan, DR; Hanania, NA; Hanrahan, JP; Sciarappa, KA, 2008)
"Supraventricular arrhythmias were common on both saline and salbutamol days (8 vs."2.67Effect of high-dose salbutamol on cardiac rhythm in severe chronic airflow obstruction: a controlled study. ( Hall, IP; Johnston, ID; Woodhead, MA, 1994)
"It is likely that arrhythmias may be precipitated in patients with hypoxaemia, acidosis or those with preexisting cardiovascular disease."2.66Hypokalaemic and electrocardiographic effects of aminophylline and salbutamol in obstructive airways disease. ( Burgess, CD; Crane, J; Graham, AN; Maling, TJ, 1987)
"Patients with COPD and a similar age, FEV1 and PaO2 who required no hospital care during the study year (1998) were randomly selected as controls."1.32Risk factors of emergency care and admissions in COPD patients with high consumption of health resources. ( Martínez, MA; Perpiñá, M; Román, P; Sánchez, L; Soler, JJ, 2004)
"No arrhythmia was seen during the hypokalaemic phase."1.29The dose-related hyper-and-hypokalaemic effects of salbutamol and its arrhythmogenic potential. ( Brandt, HD; Du Plooy, WJ; Hay, L; Kahler, CP; Schutte, PJ, 1994)

Research

Studies (47)

TimeframeStudies, this research(%)All Research%
pre-199019 (40.43)18.7374
1990's16 (34.04)18.2507
2000's5 (10.64)29.6817
2010's6 (12.77)24.3611
2020's1 (2.13)2.80

Authors

AuthorsStudies
Crouchley, J1
Bates, N1
Maxwell, AP1
Linden, K1
O'Donnell, S1
Hamilton, PK1
McVeigh, GE1
Kenyon, CC1
Fieldston, ES1
Luan, X1
Keren, R1
Zorc, JJ1
Wang, Y1
Yuan, J1
Qian, Z1
Zhang, X1
Chen, Y1
Hou, X1
Zou, J1
Hanrahan, JP2
Grogan, DR2
Baumgartner, RA2
Wilson, A1
Cheng, H1
Zimetbaum, PJ1
Morganroth, J1
Donohue, JF1
Hanania, NA1
Sciarappa, KA1
Goodwin, E1
Płusa, T1
Khorfan, FM1
Smith, P1
Watt, S1
Barber, KR1
Manthous, CA1
Soler, JJ1
Sánchez, L1
Román, P1
Martínez, MA1
Perpiñá, M1
Canepa-Anson, R1
Dawson, JR1
Frankl, WS1
Kuan, P1
Sutton, GC1
Reuben, S1
Poole-Wilson, PA1
Al-Hillawi, AH1
Hayward, R1
Johnson, NM1
Harrison, P1
Thiessen, B1
Pedersen, OF1
Crawford, SM1
Miles, DW1
Tandon, MK1
Cukier, A1
Vargas, FS1
Teixeira, LR1
Grupi, CJ1
Terra-Filho, M1
Carvalho-Pinto, RM1
Light, RW1
Hall, IP1
Woodhead, MA1
Johnston, ID1
Du Plooy, WJ1
Hay, L1
Kahler, CP1
Schutte, PJ1
Brandt, HD1
Malerba, M2
Politi, A2
Filippi, B2
Boni, E1
Grassi, V2
Bonnin, AJ1
Richmond, GW1
Musto, PK1
Volgman, AS1
Moy, JN1
Kakhnovskiĭ, IM1
Marinin, VF1
Sorokina, LA1
Markova, ZS1
Semmekrot, BA1
Monnens, LA1
Baker, EK1
Willsie, SK1
Marinac, JS1
Salzman, GA1
Rossinen, J1
Partanen, J1
Stenius-Aarniala, B1
Nieminen, MS1
Cazzola, M2
Imperatore, F1
Salzillo, A1
Di Perna, F1
Calderaro, F2
Imperatore, A1
Matera, MG2
Califano, C1
Di Pema, F1
Vinciguerra, A1
Donner, CF1
Pearlman, DS1
Stricker, W1
Weinstein, S1
Gross, G1
Chervinsky, P1
Woodring, A1
Prillaman, B1
Shah, T1
Zimmer, B1
Casson, AC1
Bayliff, CD1
George, CF1
Coskun, S2
Yuksel, H2
Tikiz, H1
Danahaliloğlu, S1
Polat, M1
Onag, A1
Mancini, G1
Mannino, F2
Larsson, S1
Mariotta, S1
Pasqua, F1
Barletta, MA1
Lehr, D1
Guideri, G1
Deacon, SP1
Del Torre, L1
Fiore, G1
Macluso, S1
Pesce, L1
Zambruni, U1
Oppenheimer, E1
Akavia, E1
Shavit, S1
Korczyn, AD1
Rotstein, Z1
Battler, A1
Rath, S1
Perek, J1
Eldar, M1
Martelli, NA1
Raimondi, AC1
Lazzari, JO1
Kotoujansky, J1
Langer, B1
Brechenmacher, C1
Schlaeder, G1
Lim, R1
Walshaw, MJ1
Saltissi, S1
Hind, CR1
Poukkula, A1
Korhonen, UR1
Huikuri, H1
Linnaluoto, M1
Crane, J1
Burgess, CD1
Graham, AN1
Maling, TJ1
Mettauer, B1
Rouleau, JL1
Burgess, JH1
Tekeres, M1
Mezey, B1
Kellényi, L1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Prospective Trial of Effect of Nebulized Bronchodilators on Heart Rate and Arrhythmias in Critically Ill Adult Patients[NCT01151579]Phase 489 participants (Actual)Interventional2008-12-31Completed
A 12-week, Double-blind, Multicenter, 3-crossover, Placebo Controlled and Randomized Trial to Investigate the Efficacy and Safety of 10mg and 5mg Bambuterol Tablets Once Daily in Patients With Chronic Obstructive Pulmonary Disease (COPD)[NCT01796730]Phase 460 participants (Actual)Interventional2013-02-28Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Arrhythmias

Any new arrhythmia documented in the medical record that occurred between breathing treatments. (NCT01151579)
Timeframe: 15 minutes after each treatment for average of 3 to 5 days

Interventionpercent (Number)
Nebulized Albuterol 2.5mg0.33
Levalbuterol 1.251.3

Heart Rate in Beats Per Minute

Average difference in Heart rate between pre and post breathing treatments (NCT01151579)
Timeframe: Five days

Interventionbpm (Mean)
Nebulized Albuterol 2.5mg-0.16
Levalbuterol 1.251.40

Total Number of Participants With Arrhythmias

Documented new arrhythmia occurring during study. (NCT01151579)
Timeframe: Five days

Interventionparticipants (Number)
Nebulized Albuterol 2.5mg2
Levalbuterol 1.253

Reviews

4 reviews available for albuterol and Arrhythmia

ArticleYear
Retrospective evaluation of acute salbutamol (albuterol) exposure in dogs: 501 cases.
    Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001), 2022, Volume: 32, Issue:4

    Topics: Albuterol; Animals; Arrhythmias, Cardiac; Dog Diseases; Dogs; Hypokalemia; Potassium; Retrospective

2022
Management of hyperkalaemia.
    The journal of the Royal College of Physicians of Edinburgh, 2013, Volume: 43, Issue:3

    Topics: Albuterol; Arrhythmias, Cardiac; Drug Therapy, Combination; Emergency Treatment; Glucose; Humans; Hy

2013
Beta 2 adrenoceptor agonists. Pharmacology, metabolic effects and arrhythmias.
    European heart journal, 1982, Volume: 3 Suppl D

    Topics: Adrenergic beta-Agonists; Albuterol; Arrhythmias, Cardiac; Blood Glucose; Epinephrine; Ethanolamines

1982
Long-term treatment with beta2-adrenostimulants in asthma. Side effects, selectivity, tolerance, and routes of administration.
    Acta medica Scandinavica. Supplementum, 1977, Volume: 608

    Topics: Administration, Oral; Adrenergic beta-Agonists; Aerosols; Albuterol; Arrhythmias, Cardiac; Asthma; E

1977

Trials

17 trials available for albuterol and Arrhythmia

ArticleYear
Arrhythmias in patients with chronic obstructive pulmonary disease (COPD): occurrence frequency and the effect of treatment with the inhaled long-acting beta2-agonists arformoterol and salmeterol.
    Medicine, 2008, Volume: 87, Issue:6

    Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Aged; Alb

2008
Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and tolerance.
    Therapeutic advances in respiratory disease, 2008, Volume: 2, Issue:2

    Topics: Albuterol; Arrhythmias, Cardiac; Bronchitis; Bronchodilator Agents; Ethanolamines; Female; Forced Ex

2008
Effects of nebulized bronchodilator therapy on heart rate and arrhythmias in critically ill adult patients.
    Chest, 2011, Volume: 140, Issue:6

    Topics: Administration, Inhalation; Adult; Aged; Aged, 80 and over; Albuterol; Analysis of Variance; Arrhyth

2011
Incidence of cardiac arrhythmias in patients taking slow release salbutamol and slow release terbutaline for asthma.
    British medical journal (Clinical research ed.), 1984, Feb-04, Volume: 288, Issue:6414

    Topics: Adult; Albuterol; Arrhythmias, Cardiac; Asthma; Delayed-Action Preparations; Female; Humans; Male; M

1984
Effect of freon inhalation on maximal expiratoryflows and heart rhythm after treatment with salbutamol and ipratropium bromide.
    European journal of respiratory diseases, 1980, Volume: 61, Issue:3

    Topics: Adult; Aerosol Propellants; Aerosols; Albuterol; Arrhythmias, Cardiac; Asthma; Atropine Derivatives;

1980
Arrhythmogenic effects of combined orally administered theophylline and albuterol in patients with chronic obstructive pulmonary disease.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 1994, Volume: 27, Issue:12

    Topics: Administration, Oral; Aged; Albuterol; Arrhythmias, Cardiac; Bronchodilator Agents; Drug Therapy, Co

1994
Effect of high-dose salbutamol on cardiac rhythm in severe chronic airflow obstruction: a controlled study.
    Respiration; international review of thoracic diseases, 1994, Volume: 61, Issue:4

    Topics: Aged; Albuterol; Arrhythmias, Cardiac; Carbon Dioxide; Electrocardiography, Ambulatory; Female; Forc

1994
Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia.
    Chest, 1998, Volume: 114, Issue:2

    Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Albuterol; Arrhythmias, Cardiac; Cross-O

1998
Oral bambuterol compared to inhaled salmeterol in patients with partially reversible chronic obstructive pulmonary disease.
    European journal of clinical pharmacology, 1999, Volume: 54, Issue:11

    Topics: Administration, Inhalation; Administration, Oral; Adult; Aged; Albuterol; Arrhythmias, Cardiac; Bron

1999
Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 1999, Volume: 82, Issue:3

    Topics: Adolescent; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adult; Albuterol; Androst

1999
Standard dose of inhaled albuterol significantly increases QT dispersion compared to low dose of albuterol plus ipratropium bromide therapy in moderate to severe acute asthma attacks in children.
    Pediatrics international : official journal of the Japan Pediatric Society, 2001, Volume: 43, Issue:6

    Topics: Acute Disease; Administration, Inhalation; Adolescent; Albuterol; Arrhythmias, Cardiac; Asthma; Bron

2001
Lower arrythmogenic risk of low dose albuterol plus ipratropium.
    Indian journal of pediatrics, 2001, Volume: 68, Issue:10

    Topics: Albuterol; Arrhythmias, Cardiac; Asthma; Bronchodilator Agents; Female; Humans; Infant; Ipratropium;

2001
[Intravenous salbutamol in the treatment of bronchial spasm].
    Minerva medica, 1978, Jan-28, Volume: 69, Issue:4

    Topics: Aerosols; Albuterol; Arrhythmias, Cardiac; Bronchial Spasm; Clinical Trials as Topic; Drug Evaluatio

1978
[Changes in the heart rhythm and slow-release beta-2 agonist therapy (peroral) in asthmatic patients. A Holter study].
    Recenti progressi in medicina, 1992, Volume: 83, Issue:12

    Topics: Administration, Oral; Adult; Albuterol; Arrhythmias, Cardiac; Asthma; Delayed-Action Preparations; E

1992
Asthma, cardiac arrhythmias, and albuterol aerosol.
    Chest, 1986, Volume: 89, Issue:2

    Topics: Adult; Aerosols; Aged; Albuterol; Arrhythmias, Cardiac; Asthma; Cardiac Complexes, Premature; Clinic

1986
Theophylline and salbutamol in combination in patients with obstructive pulmonary disease and concurrent heart disease: effect on cardiac arrhythmias.
    Journal of internal medicine, 1989, Volume: 226, Issue:4

    Topics: Aged; Albuterol; Arrhythmias, Cardiac; Clinical Trials as Topic; Delayed-Action Preparations; Drug T

1989
Hypokalaemic and electrocardiographic effects of aminophylline and salbutamol in obstructive airways disease.
    The New Zealand medical journal, 1987, May-27, Volume: 100, Issue:824

    Topics: Administration, Inhalation; Adult; Albuterol; Aminophylline; Arrhythmias, Cardiac; Asthma; Clinical

1987

Other Studies

26 other studies available for albuterol and Arrhythmia

ArticleYear
Safety and effectiveness of continuous aerosolized albuterol in the non-intensive care setting.
    Pediatrics, 2014, Volume: 134, Issue:4

    Topics: Adolescent; Albuterol; Arrhythmias, Cardiac; Bronchodilator Agents; Child; Child, Preschool; Cohort

2014
β2 adrenergic receptor activation governs cardiac repolarization and arrhythmogenesis in a guinea pig model of heart failure.
    Scientific reports, 2015, Jan-08, Volume: 5

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Amrinone; Animals; Arrhythmias, Ca

2015
[Agonists of beta2 adrenergic receptor in the therapy of obstructive diseases].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2010, Volume: 28, Issue:163

    Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Albuterol; Arrhythmias, Cardiac; Card

2010
Aerosols and details.
    Chest, 2012, Volume: 141, Issue:5

    Topics: Albuterol; Arrhythmias, Cardiac; Bronchodilator Agents; Female; Heart Rate; Humans; Ipratropium; Mal

2012
Risk factors of emergency care and admissions in COPD patients with high consumption of health resources.
    Respiratory medicine, 2004, Volume: 98, Issue:4

    Topics: Administration, Inhalation; Aged; Albuterol; Arrhythmias, Cardiac; Bronchodilator Agents; Case-Contr

2004
Incidence of cardiac arrhythmias in patients taking slow release salbutamol and terbutaline for asthma.
    British medical journal (Clinical research ed.), 1984, Mar-17, Volume: 288, Issue:6420

    Topics: Adult; Albuterol; Arrhythmias, Cardiac; Humans; Middle Aged; Terbutaline

1984
Salbutamol and cardiac arrhythmias.
    Current medical research and opinion, 1981, Volume: 7, Issue:6

    Topics: Aged; Albuterol; Arrhythmias, Cardiac; Electrocardiography; Female; Heart Rate; Humans; Infusions, P

1981
Cardiopulmonary effects of fenoterol and salbutamol aerosols.
    Chest, 1980, Volume: 77, Issue:3

    Topics: Aerosols; Albuterol; Arrhythmias, Cardiac; Asthma; Blood Pressure; Dose-Response Relationship, Drug;

1980
The dose-related hyper-and-hypokalaemic effects of salbutamol and its arrhythmogenic potential.
    British journal of pharmacology, 1994, Volume: 111, Issue:1

    Topics: Albuterol; Animals; Arrhythmias, Cardiac; Blood Pressure; Dose-Response Relationship, Drug; Electroc

1994
Controlled-release oral salbutamol and cardiac arrhythmias in asthmatic patients.
    Chest, 1993, Volume: 104, Issue:3

    Topics: Administration, Oral; Adult; Albuterol; Arrhythmias, Cardiac; Asthma; Delayed-Action Preparations; F

1993
Repeated inhalation of nebulized albuterol did not induce arrhythmias in a patient with Wolff-Parkinson-White syndrome and asthma.
    Chest, 1993, Volume: 103, Issue:6

    Topics: Administration, Inhalation; Adult; Albuterol; Arrhythmias, Cardiac; Asthma; Contraindications; Elect

1993
[Cardiac monitoring in bronchial asthma patients taking salben].
    Terapevticheskii arkhiv, 1996, Volume: 68, Issue:3

    Topics: Administration, Inhalation; Adult; Aged; Albuterol; Arrhythmias, Cardiac; Asthma; Bronchodilator Age

1996
A warning for the treatment of hyperkalaemia with salbutamol.
    European journal of pediatrics, 1997, Volume: 156, Issue:5

    Topics: Adrenergic beta-Agonists; Albuterol; Animals; Arrhythmias, Cardiac; Child; Humans; Hyperkalemia; Pap

1997
Continuously nebulized albuterol in severe exacerbations of asthma in adults: a case-controlled study.
    The Journal of asthma : official journal of the Association for the Care of Asthma, 1997, Volume: 34, Issue:6

    Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Arrhythmia

1997
Salbutamol inhalation has no effect on myocardial ischaemia, arrhythmias and heart-rate variability in patients with coronary artery disease plus asthma or chronic obstructive pulmonary disease.
    Journal of internal medicine, 1998, Volume: 243, Issue:5

    Topics: Administration, Inhalation; Aged; Albuterol; Arrhythmias, Cardiac; Asthma; Blood Pressure; Bronchodi

1998
The clinical effects and cost-avoidance of a change in perioperative bronchodilator use.
    The Canadian journal of hospital pharmacy, 1994, Volume: 47, Issue:4

    Topics: Aerosols; Albuterol; Arrhythmias, Cardiac; Bronchodilator Agents; Cost Savings; Drug Costs; Drug Uti

1994
[Side-effects of beta-adrenergic drugs].
    Minerva medica, 1976, Mar-13, Volume: 67, Issue:15

    Topics: Adrenergic beta-Agonists; Albuterol; Angina Pectoris; Arrhythmias, Cardiac; Headache; Humans; Hypert

1976
Hemodynamic alterations in isoproterenol-induced cardiac arrhythmias in corticoid-treated rats.
    Journal of pharmaceutical sciences, 1978, Volume: 67, Issue:10

    Topics: Adrenal Cortex Hormones; Albuterol; Animals; Arrhythmias, Cardiac; Blood Pressure; Desoxycorticoster

1978
Metabolic effects of salbutamol.
    British medical journal, 1977, Mar-05, Volume: 1, Issue:6061

    Topics: Albuterol; Arrhythmias, Cardiac; Humans

1977
[Salbutamol therapy of chronic bronchopathic patients with cardiac arrhythmias].
    Il Torace, 1976, Volume: 18, Issue:1-2

    Topics: Aged; Albuterol; Arrhythmias, Cardiac; Asthma; Chronic Disease; Female; Heart Rate; Humans; Lung Dis

1976
Sympathomimetic amines and cardiac arrhythmias.
    Cardiovascular research, 1990, Volume: 24, Issue:9

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Albuterol; Animals; Arrhythmias, Cardiac;

1990
Acute hemodynamic and arrhythmogenic effects of high-dose intravenous salbutamol in patients with chronic left ventricular dysfunction.
    Clinical cardiology, 1990, Volume: 13, Issue:7

    Topics: Adult; Aged; Albuterol; Arrhythmias, Cardiac; Cardiac Output; Electrocardiography, Ambulatory; Femal

1990
[Tocolysis using salbutamol in cases of cardiac rhythm disorders in the mother. Apropos of 4 cases].
    Journal de gynecologie, obstetrique et biologie de la reproduction, 1985, Volume: 14, Issue:7

    Topics: Adult; Albuterol; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Female; Humans; Labor, Induced

1985
Cardiac arrhythmias during acute exacerbations of chronic airflow limitation: effect of fall in plasma potassium concentration induced by nebulised beta 2-agonist therapy.
    Postgraduate medical journal, 1989, Volume: 65, Issue:765

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Albuterol; Arrhythmias, Cardiac; Asthma; Humans; Male

1989
Detrimental arrhythmogenic and sustained beneficial hemodynamic effects of oral salbutamol in patients with chronic congestive heart failure.
    American heart journal, 1985, Volume: 109, Issue:4

    Topics: Aged; Albuterol; Arrhythmias, Cardiac; Blood Pressure; Cardiac Output; Electrocardiography; Female;

1985
Effect of beta receptor-stimulating drugs on the cardiovascular and respiratory function of critically ill patients with serious heart disorders.
    Resuscitation, 1974, Volume: 3, Issue:3

    Topics: Albuterol; Arrhythmias, Cardiac; Asthma; Blood Pressure; Cardiovascular System; Female; Heart; Heart

1974